Bromelain-based enzymatic debridement of e-cigarette burns: a single unit experience. (2nd November 2019)

• Record Type: Journal Article
• Authors: Ho, Weiguang; Jones, Christopher D.; Widdowson, Daniel; Bahia, Hilal
• Is Part Of: Journal of wound care. Volume 28:Number 11(2019)
• Page Start: 758
• Page End: 761
• Publication Date: 2019-11-02
• Subjects: bromelain -- burns -- electronic cigarette -- enzymatic debridement; Wounds and injuries -- Treatment -- Periodicals; Wound healing -- Periodicals; 617.1
• DOI: 10.12968/jowc.2019.28.11.758
• Languages: English
• ISSNs: 0969-0700

Abstract

Abstract : Objective: It is widely accepted that the early debridement of burns improves outcome. There is increasing evidence that enzymatic debridement is an effective technique for removal of full-thickness and deep-dermal burns, reducing blood loss and often the need for autologous skin grafting by avoiding over excision of the burn. We aim to highlight the potential use of this form of debridement as an alternative to surgical management in patients with electronic cigarette (e-cigarette)-associated flame burn injuries. Methods: This case series presents the use of Nexobrid (MediWound Ltd, Israel), a non-surgical, bromelain-based enzymatic debridement technique, in patients with deep partial-thickness burns (range: 1–3% total body surface area), avoiding the need for autologous skin grafting. Results: Burn wounds in two patients healed within 14 days without complications or the need for further surgical intervention. Another patient required further dressings after discharge but failed to attend follow-up appointments. These results are comparable with those reported by others using conservative management of e-cigarette burns. Conclusion: The authors wish to raise awareness of the potential for a combination of thermal and chemical burns related to e-cigarette explosions. Chemical burns should be excluded by pH testing of the burn wound. From our experience, small e-cigarette-associated flame burns can be considered for management with enzymatic debridement.